Skip to main content

Table 1 Main characteristics of colorectal cancer cases and controls

From: A case–control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer

 

Controls (n = 252)

Cases (n = 224)

P value

 

n (%)

n (%)

 

Male gender

144 (57)

137 (61)

0.37

Median age (years) [IQR]

66.4 [58.4-74.8]

69.6 [60.6-75.9]

0.04

Median current BMI (kg/m2) [IQR]

26.9 [24.2-30.4]

25.9 [23.3-29.8]

0.05

Median Waist/Hip ratio [IQR]

0.93 [0.88-1.00]

0.95 [0.89-1.01]

0.12

Recent weight loss ≥5 kg

30 (12)

53 (24)

<0.001

Severe denutrition

6 (2)

15 (7)

0.02

Family history of colorectal cancer

  

0.06

 No

220 (87)

178 (79)

 

 Yes

22 (9)

29 (13)

 

 Unknown

10 (4)

17 (8)

 

Smoking

  

0.72

 Never smoker

113 (45)

107 (48)

 

 Ex smoker

103 (41)

89 (40)

 

 Current smoker

37 (15)

28 (13)

 

Alcohol consumption

  

0.08

 None

47 (19)

39 (18)

 

 <5 drinks/week

105 (42)

74 (33)

 

 ≥5 drinks/week

98 (39)

109 (49)

 

Physical activity

  

0.29

 Low

65 (26)

70 (31)

 

 Medium

139 (55)

108 (48)

 

 High

48 (19)

46 (21)

 

Type 2 diabetes

40 (16)

49 (22)

0.09

Median HOMA-IR

0.81 [0.42-1.98]

0.92 [0.44-2.15]

0.28

Median pre-albumin (g/L)

0.26 [0.22-0.30]

0.23 [0.19-0.28]

<0.001

Aspirin or NSAID use in the last month

51 (20)

52 (23)

0.43

Statin use in the last month

60 (24)

m 69 (31)

0.09

TNM stage

   

 (Tis)

 

13 (5.8)

 

 Stage I

 

57 (25.4)

 

 Stage II

 

77 (34.4)

 

 Stage III

 

60 (27.1)

 

 Stage IV/unstaged

 

17 (7.6)